Trial · NCT03486782
Dual Site-dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Stroke Patients
NCT03486782, Not applicable, Completed, Samsung Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Dual Site-dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Stroke Patients. Trials, record NCT03486782. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03486782
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Dual Site-dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Stroke Patients
- NCT number
- NCT03486782
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 30 participants, actual
- Lead sponsor
- Samsung Medical Center
- Conditions
- Stroke, Aphasia, Cognitive Impairment
- Interventions
- IFG stimulation, DLPFC stimulation, aphasia therapy
- First posted
- 2018-04-03
- Last updated
- 2020-05-27
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes in Korean Boston naming test | Baseline and after intervention (approximately 2 weeks) | measures naming ability thorough picture naming test |
| Primary | Changes in Korean Western Aphasia Battery | Baseline and after intervention (approximately 2 weeks) | assessment of language function and provide aphasia quotients |
| Secondary | Digit span test | Baseline and after intervention (approximately 2 weeks) | measures memory span |
| Secondary | Korea Montreal Cognitive Assessment | Baseline and after intervention (approximately 2 weeks) | measure cognitive function |
| Secondary | Korean Color Word Stroop test | Baseline and after intervention (approximately 2 weeks) | measures selective attention and executive function |
| Secondary | Controlled Oral Word Association Test | Baseline and after intervention (approximately 2 weeks) | measure verbal fluency |
| Secondary | Changes of Cortical activation | Baseline and after intervention (approximately 2 weeks) | Cortical activation is measured by functional Near-Infrared-Spectroscopy (fNIRS) (NIRScout, NIRx, Germany) |
| Secondary | Changes in brain activation of resting-state and task functional MRI | Baseline and after intervention (approximately 2 weeks) | Neuroplasticity measure |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Picture Naming Test | Primary outcome | ConductCognition |
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03486782
GET https://conductscience.org/api/trials/v1/NCT03486782/registered